MEU is a leading biopharmaceutical company dedicated to advancing the global vaccine industry through cutting-edge research and strategic partnerships. With a focus on research and development, MEU is committed to developing innovative vaccines that address critical public health challenges worldwide. By leveraging a multidisciplinary approach and collaborating with key stakeholders, MEU aims to accelerate the discovery, development, and commercialization of novel vaccines to improve global health outcomes. At World Vaccine Congress Washington 2025, MEU will showcase its latest advancements in vaccine technology and seek strategic partnerships to further enhance its impact on the global vaccine landscape.